The most famous of all probiotics – L. bulgaricus, now reclassified as L. delbrueckii, has long been known to promote wellbeing and longevity. Find out how this probiotic can boosts your immunity and combat infections.
What is Lactobacillus delbrueckii?
Lactobacillus delbrueckii is a species of lactic acid bacteria that is widely used in dairy fermentation (R).
Previously known as L. bulgaricus and L. lactis, these probiotics were shown to have highly similar DNA to L. delbrueckii, and have since been considered to be subspecies of L. delbrueckii (R).
L. delbrueckii ssp. bulgaricus was discovered more than a century ago in 1905, as a result of a study into the unusual longevity of mountain villagers in Bulgaria (and was thus at the time named L. bulgaricus) (R).
In 1912, the New York Times wrote an article about the use of fermented yogurts with L. delbrueckii ssp. bulgaricus in Bulgaria titled “Metchnikoff Confirmed in His Theory of Long Life” (R).
Today, L. delbrueckii ssp. bulgaricus is one of the economically most important lactic acid bacteria and is used worldwide in the production of yogurt (R).
Health Benefits of L. delbrueckii
1) L. delbrueckii Boosts Immunity
L. delbrueckii Stimulates Th1 Immunity
L. delbrueckii Combats Bacterial and Viral Infections
L. delbrueckii increases survival in mice infected with Listeria monocytogenes (R).
Similarly, L. delbrueckii ssp. bulgaricus increases survival in mice infected with Klebsiella pneumoniae and L. monocytogenes (R).
Yogurt fermented with L. delbrueckii ssp. bulgaricus helps mice fight the influenza virus by increasing natural killer cell activity, and increasing anti-influenza virus antibodies (R).
L. delbrueckii Prevents the Aging of the Immune System
L. delbrueckii ssp. bulgaricus could favor the maintenance of an adequate immune response in the elderly, mainly by slowing the aging of the T-cell subpopulations and increasing the number of immature T cells which are potential responders to new antigens (R).
2) L. delbrueckii May Reduce Inflammation
L. delbrueckii ssp. lactis was shown to possess anti-inflammatory effects (R).
Both live bacteria and isolated L. delbrueckii DNA were shown to be efficacious in attenuating intestinal inflammation (R).
L. delbrueckii May Alleviate Atopic Dermatitis
Oral intake of heat-killed L. delbrueckii ssp. bulgaricus inhibited the development of atopic dermatitis and the elevation of inflammation markers in mice (R).
3) L. delbrueckii May Alleviate Arthritis
Oral intake of skimmed milk fermented with L. delbrueckii ssp. bulgaricus markedly inhibits the development of arthritis in mice (R).
4) L. delbrueckii Combats Allergies
L. delbrueckii ssp. bulgaricus degrades the allergenic whey protein β-lactoglobulin and inhibits IgE binding in allergic patients (R).
5) L. delbrueckii is Beneficial for the GI Tract
L. delbrueckii May Beneficially Modify the Gut Microbiota
L. delbrueckii increases the number of beneficial Bifidobacteria in mice(R).
L. delbrueckii May Protect from Infection-Caused Intestinal Damage
L. delbrueckii ssp. lactis ameliorates mucosal barrier destruction caused by Salmonella typhimurium infection in human GI cells (R).
L. delbrueckii May Ameliorate Antibiotic-Induced Microbiota Dysfunction
L. delbrueckii microcapsules relieve intestinal tissue damage in mice and ameliorate antibiotic-induced intestinal microbiota dysfunction (R).
C. difficile is one of the main causes of antibiotic-associated diarrhea, and L. delbrueckii ssp. bulgaricus was shown to inhibit C. difficile-mediated GI cell toxicity (R).
L. delbrueckii May Ameliorate Intestinal Inflammation
L. delbrueckii ssp. lactis has anti-inflammatory properties in acute intestinal inflammation in mice (R).
L. delbrueckii ssp. bulgaricus ameliorates colitis in mice (R).
L. delbrueckii ssp. bulgaricus pretreatment protects newborn rats infected with E. sakazakii from developing necrotizing enterocolitis, resulting in improved survival (R).
L. delbrueckii Combats H. pylori
L. delbrueckii ssp. bulgaricus inhibits H. pylori in the laboratory (R).
L. delbrueckii ssp. bulgaricus, together with Streptococcus thermophiles, improves H. pylori eradication rates in infected patients (R).
6) L. delbrueckii May Combat Cancer
A lysozyme lysate from L. delbrueckii ssp. bulgaricus has shown antitumor activity in mice and human cells (R).
L. delbrueckii ssp. bulgaricus was found to inhibit intestinal carcinogenesis in rats, ear-duct tumors in rats, and tracheal carcinogenesis in hamsters (R). This probiotic was also reported to inhibit the growth of sarcoma (R), leukemia, plasmacytoma, adenocarcinoma, melanosarcoma, and spontaneous tumors in mice (R).
- L. delbrueckii, in many cases, induces the production of inflammatory cytokines IL-12, TNF-α, and IFN-γ (R,R,R,R), and increases NK cell activity (R,R, R).
- This probiotic also increases IL-1 production (R,R), and in some cases IL-6, and may mediate endogenous pyrogenic activity (fever) (R).
- L.delbrueckii increases IgA and IgG(1) (R,R).
- L. delbrueckii increases antimicrobial peptide hBD-2 (R).
- However, it was also shown that, in mice with arthritis, L. delbrueckii inhibits secretion of IFN-γ, IL-6, TNF-α and the chemokine MCP-1 by accessory cells (R).
- In some cases, L. delbrueckii also increases IL-10 (R,R), and decreased pro-inflammatory IL-8 (R).
- In inflamed tissues, L. delbrueckii reduced IL-6 levels and serum amyloid A (R), decreased the production of TGF-β, and IL-12 and caused an expansion of CD4+Foxp3+ regulatory T cells (R).
- Isolated L. delbrueckii DNA was shown to be as efficacious in attenuating intestinal inflammation as the treatment with live bacteria (R).
- L. delbrueckii degrades the allergenic whey protein β-lactoglobulin and inhibits IgE binding (R).
L. delbrueckii is considered safe, but should be avoided in immunocompromised individuals, people with organ failure, and dysfunctional gut barrier, where probiotics may lead to infection.